The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response

DARC 方面乳腺癌差异 - 非洲血统和癌症相关免疫反应

基本信息

批准号：
10493136
负责人：
Melissa B Davis
金额：
$ 53.58万
依托单位：
WEILL MEDICAL COLL OF CORNELL UNIV
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-09-23 至 2026-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10493136
关键词：
3-Dimensional Affect Africa African African American African American population African Caribbean African ancestry Age Alleles Anthropology Area Automobile Driving Biodiversity Biology Breast Cancer Patient Breast Cancer Treatment Caribbean region Cells Characteristics Clinical Country Coupled Cytometry DNA Data Data Set Diabetes Mellitus Diagnosis Disease Epithelial Ethiopia Etiology Gene Expression Gene Expression Profile Genes Genetic Genetic Risk Genetic Variation Genomics Ghana Healthcare Heterogeneity High Prevalence Immune Immune response Immunologics Immunotherapy In Situ Incidence Individual Infiltration Inflammation Inflammatory Investigation Kenya Latinx Leukocytes Link Malignant Neoplasms Mammary Neoplasms Modeling Myelogenous Nigeria Obesity Organoids Outcome Pathologic Pathologist Pathology Pathway interactions Patient Self-Report Patients Pattern Phenotype Population Population Genetics Population Heterogeneity Primary Neoplasm Privatization Proteins Proteomics Race Regulation Reporting Risk Side Stage at Diagnosis Surgical Oncologist Survival Rate Tissue-Specific Gene Expression Tumor Biology Tumor Subtype Tumor-infiltrating immune cells Variant Woman Work base cancer genome cancer health disparity cancer subtypes caucasian American cell behavior cell type cohort comorbidity gene network genetic variant genome sequencing health disparity health outcome disparity improved inflammatory marker innovation insight malignant breast neoplasm mortality mortality disparity multi-ethnic multidisciplinary multiple omics multiplexed imaging neoplastic cell novel patient stratification personalized care population based prognostic prospective recruit response targeted treatment transcriptome transcriptome sequencing translational study treatment response triple-negative invasive breast carcinoma tumor tumor heterogeneity tumor microenvironment tumor-immune system interactions whole genome

项目摘要

PROJECT SUMMARY (tech abs) Even with the typical delays in diagnosis, more advanced stage distribution at diagnosis, and inadequate multidisciplinary breast cancer treatment, these combined factors do not completely explain disparities in breast cancer mortality outcomes, which persist after controlling for stage at diagnosis – and have been so for the past 50 years. The approximately two-fold increased risk of TNBC in AA women has been confirmed by population-based incidence rates regionally as well as nationally and across all age intervals. Compared to non-TNBC, triple negative disease has been confirmed to be an adverse prognostic feature in AA patients, driving some of the mortality disparities. We hypothesize that altered mechanisms of tumor immune responses, which underlies TNBC tumor biology differences between SRR, are caused by population-private genetic variants among individuals with shared west African ancestry. These evolutionarily selected variants alter immune cell behavior and inflammatory mechanisms, leading to novel tumor-immune cell types and significant differences in leukocyte infiltration patterns, which may be associated with poor outcomes. We will perform an innovative multiomics investigation of African-specific gene expression in TNBC, linked to immunological tumor phenotypes. We will harness the novelty of rarely-investigated breast cancer patient populations from diverse African regions with TNBC cases from g admixed populations (i.e. African-American and Afro-Caribbean). The most impactful innovation of this study is the characterization of differential gene expression, coupled with integrated proteomics data, to identify novel tumor phenotypes that are shared among women of the African diaspora. This work will be transformative to our understanding of tumor heterogeneity and biological diversity across patient groups. We propose the follow aims: 1- Determine the ancestry- associated differential gene expression profiles of immune and inflammatory-related genes in primary tumors across an African-enriched cohort of 400 clinically annotated TNBC cases, to immune profiles linked to shared west African genetic ancestry. 2- Characterize ancestry-associated differences in pathological tumor immune response characteristics, including differences in tumor inflammation and/or tumor infiltration of specific immune cell types. 3-Create an African-enriched panel of ex vivo models to validate/investigate the ancestry-associated drivers of altered genetic pathways and immune responses. By completing these aims we expect to yield an African-enriched set of population-private, validated eQTLs, associated with TNBC immune response mechanisms that can be further interrogated by our authenticated ex vivo models.

项目摘要（技术ABS）即使存在典型的诊断延迟、诊断时分期分布更晚以及多学科不足的情况乳腺癌治疗，这些综合因素并不能完全解释乳腺癌死亡率结果的差异，在控制了诊断阶段后，这种情况仍然存在——并且在过去 50 年里一直如此。 AA 女性 TNBC 的风险增加已被区域和人群的发病率证实与非 TNBC 相比，三阴性疾病在全国范围内均被证实是一种不利因素。 AA 患者的预后特征导致了一些死亡率差异，我们认为这改变了 AA 患者的机制。免疫肿瘤反应是 SRR 之间 TNBC 肿瘤生物学差异的基础，是由人群-私人引起的具有共同西非血统的个体之间的遗传变异这些进化选择的变异会改变免疫。细胞行为和炎症机制，导致新的肿瘤免疫细胞类型和显着差异白细胞浸润模式，这可能与不良结果有关，我们将进行创新的多组学研究。我们将利用 TNBC 中与免疫肿瘤表型相关的非洲特异性基因表达的研究。来自非洲不同地区的乳腺癌患者群体中的 TNBC 病例很少被调查，这具有新颖性这项研究最有影响力的创新是混合人群（即非洲裔美国人和非洲裔加勒比人）。差异基因表达的表征，结合整合的蛋白质组学数据，以确定新的肿瘤表型这项工作将改变我们对肿瘤的理解。我们提出以下目标：1-确定祖先- 原发性肿瘤中免疫和炎症相关基因的相关差异基因表达谱非洲丰富的 400 例临床注释 TNBC 病例队列，其免疫特征与西非共有遗传相关 2- 描述病理性肿瘤免疫反应特征中与血统相关的差异，包括肿瘤炎症和/或特定免疫细胞类型的肿瘤浸润的差异3-创建富含非洲的细胞。一组离体模型，用于验证/研究遗传途径和免疫改变的祖先相关驱动因素通过完成这些目标，我们期望产生一组丰富的非洲人口私人、经过验证的 eQTL，与 TNBC 免疫反应机制相关，可以通过我们经过验证的离体模型进一步询问。